1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Innovative Health Initiative Joint Undertaking (IHI JU) is a grant from the European Commission that funds collaborative, cross-sector health research projects spanning pharmaceutical, digital, IT, medical devices, and diagnostics industries.
The IHI JU aims to translate health research and innovation into tangible patient benefits by supporting breakthroughs that cross traditional sector boundaries, such as medical device-drug combinations and AI diagnostics. Projects span the full spectrum of care from prevention to diagnosis and treatment, with a focus on unmet public health needs and making Europe's health industries globally competitive.
Eligible applicants include health-related industries, SMEs, academic institutions, clinical organizations, patient organizations, and other health research entities from EU member states. Award amounts vary by project call.
Get alerted about grants like this
Get emailed when new opportunities from “European Commission” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Innovative Health Initiative JU – IHI JU | European Union Innovative Health Initiative Joint Undertaking (IHI JU) Role : To translate health research and innovation into tangible benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research.
Executive Director: Dr Niklas Blomberg Partners : The EU (represented by the European Commission, COCIR (medical imaging, radiotherapy, health ICT and electromedical industries); EFPIA (biopharmaceutical industry), EuropaBio (biotechnology industry); MedTech Europe (medical technology industry) and Vaccines Europe (vaccine industry).
Location : Brussels (Belgium) Website : IHI Joint Undertaking Science is driving new developments that often span different sectors within the life science community. As a result, an increasing number of patients already use medical devices, digital technologies and e-health services alongside medicines as part of their healthcare.
Looking to the future, it’s clear that new breakthroughs will increasingly involve cross-sector discoveries , such as medical device-drug combinations or AI diagnostics. Yet all too often, the industrial sectors involved in health research and care (pharmaceutical, digital, IT, medical devices, diagnostics, etc.) work in isolation. We urgently need an innovative, more integrated approach to health research and healthcare .
turn health research and innovation into real benefits for patients and society deliver safe, effective health innovations that cover the entire spectrum of care – from prevention to diagnosis and treatment – particularly in areas where there’s an unmet public health need make Europe’s health industries globally competitive.
It funds collaborative, cross-sector research projects that bring together all the parties involved in health research, including: health-related industries small and medium-sized enterprises (SMEs) IHI builds on the successes and lessons learned through the Innovative Medicines Initiative , a partnership between the EU and the pharmaceutical industry.
IMI demonstrated that a public-private partnership approach delivers results in areas where there is a lack of safe, effective treatments (e.g. dementia ) and/or where the impact on public health is greatest (e.g. diabetes, antimicrobial resistance ). Patients can influence research into their conditions; in the longer term, they and society in general will benefit from faster access to better, safer medicines.
Academic researchers and SMEs gain knowledge and access to research funding. Larger companies gain knowledge and tools to improve their R&D activities. All project participants benefit from the expertise of other partners and the opportunity to translate scientific discoveries into useful tools and resources that will ultimately help improve healthcare.
Innovative Health Initiative Joint Undertaking (IHI JU) Name Innovative Health Initiative Joint Undertaking (IHI JU) Website https://www. ihi. europa.
eu/ Email infodesk ihi [dot] europa [dot] eu Phone number +32 2 221 81 81 Postal address IHI JU TO 56
According to the current listing, eligibility includes: Nonprofit organizations, including NGOs, involved in health research and innovation within EU member states. Confirm the full requirements in the official notice before applying.
Innovative Health Initiative Joint Undertaking (IHI JU) is funded by European Commission. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.